Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can rewards for personal goals reduce meth overdoses?

NCT ID NCT05700994

Disease control Sponsor: Oregon Health and Science University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering incentives for achieving self-identified harm reduction goals (like completing overdose prevention training or setting daily life goals) can reduce overdose and increase treatment engagement among people who use methamphetamine. Over 1,200 participants are involved, comparing peer-facilitated goal-setting with incentives to standard care. The approach focuses on harm reduction rather than abstinence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Peer-facilitated contingency management (behavioral intervention with incentives)
What this could lead to
If successful, this approach could reduce overdose rates and help more people engage with treatment and harm reduction services.
What could go wrong
This is a large but early-stage behavioral study; results depend on participant motivation and may not generalize to all settings. Incentives may not sustain long-term behavior change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,283 people

The number who actually took part.

Started

Nov 2023

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 105 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: This intervention is at the site level. Community-based organization sites are eligible if they: * Use peer support specialists to provide direct outreach and harm reduction services to people who use drugs * Are willing to be trained in the two strategies for peer-facilitated contingency management Clients who: * Age 18 and older * Any stimulant (methamphetamine, cocaine) use in the past 30 days * Willing to accept peer services * Willing to complete initial and follow-up assessments with peer * Able to communicate in English or Spanish Exclusion Criteria: Community-based organization sites who: * Do not use peer support specialists to provide direct outreach and harm reduction services to people who use drugs * Are not willing to be trained in the two strategies for peer-facilitated contingency management Clients who: • Present any danger or threat of violence to peers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Methamphetamine abuse are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amphetamine abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Methamphetamine abuse

Contacts and locations

Locations

  • Comagine Health

    Portland, Oregon, 97232, United States

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.